AI4MedImaging- Medical Solutions S.A.
Joaquin Azpilicueta serves as the Medical Director at Elixir Medical Corporation since May 2023, contributing to advancements in arterial restoration with the DynamX system. As an Associate Professor at IE Business School since June 2020, Joaquin also provides business advisory expertise to Xana, a neurotechnology firm focused on developing non-invasive neurostimulator systems for wellness. Joaquin holds the position of Chief Executive Officer at Alpha Innomed and has held senior advisory and management roles at AI4MedImaging and Exergen Corporation, where responsibilities included international medical direction. Previous leadership roles at EP Solutions and Haemonetics involved driving growth and profitability across multiple regions, including EMEA and Latin America, while early career experiences include significant roles at Gambro and Welch Allyn. Joaquin Azpilicueta holds a medical degree in Cardiology from the University of Navarra and an MBA from IE Business School, along with certification in business administration from Instituto de Consejeros y Administradores.
This person is not in any teams
This person is not in any offices
AI4MedImaging- Medical Solutions S.A.
AI4MedImaging is a company specialized in applying artificial intelligence (AI) to medical imaging. AI4MedImaging is currently focused on a critical medical need in cardiac magnetic resonance imaging. This imaging modality involves the manual or semi-automatic segmentation of cardiac chambers and the visual interpretation of left ventricle wall motion. This is a tedious and subjective task with significant inter-rater variability. AI4MedImaging developed an AI-based software that performs a fully automatic segmentation of both ventricles and an automatic identification of patients with normal wall motion. This results in a reduction of reporting time by more than 40%, allowing the experts to focus in abnormal or complex cases. The AI4MedImaging solution is "software as a medical device" (SaMD) that aims to automatize the interpretation of cardiac magnetic resonance imaging (CMR) using artificial intelligence.